beta-lapachone has been researched along with Cancer of Head in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, LS | 1 |
| Reddy, S | 1 |
| Lin, ZH | 1 |
| Liu, S | 1 |
| Park, H | 1 |
| Chun, SG | 1 |
| Bornmann, WG | 1 |
| Thibodeaux, J | 1 |
| Yan, J | 1 |
| Chakrabarti, G | 1 |
| Xie, XJ | 1 |
| Sumer, BD | 1 |
| Boothman, DA | 1 |
| Yordy, JS | 1 |
1 other study available for beta-lapachone and Cancer of Head
| Article | Year |
|---|---|
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Topics: Adenosine Triphosphate; Animals; Catalase; Cell Death; Cell Line, Tumor; Cell Survival; Disease Mode | 2016 |